Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 17, 2016

View Archived Issues

Akros initiates phase II trial of JTE-051 in active rheumatoid arthritis

Mitsubishi Tanabe begins phase II trial of MT-3995 in NASH

Obeticholic acid granted positive CHMP opinion as treatment of primary biliary cholangitis

PhoreMost and University of Cambridge collaborate to identify novel targets

Japan Tobacco and JW Pharmaceutical enter license agreement for JTZ-951 in Republic of Korea

Clinical trial update for the INEXAS phase IIa study evaluating AZD-9412 in patients with asthma

Sunesis Pharmaceuticals submits response to EMA regarding vosaroxin MAA

Early first-in-human results indicate PTC-596 can achieve active plasma levels in cancer patients

EMA committee recommends approval of Rekovelle

Inhibition of APOBEC3B activity improves clinical benefit of tamoxifen in breast cancer

Allegro Ophthalmics' DEL MAR study meets primary and secondary endpoints

Clementia Pharmaceuticals reports positive results from phase II study of palovarotene

NEDD4L plays a critical role in the regulation of cortex development

Hua reports promising phase II results of glucokinase activator HMS-5552

TSHZ3 identified as a new gene linked to autism spectrum disorders

Myocardial PET imaging with CardioPET shows promise in phase II study

Bristol-Myers Squibb receives positive CHMP opinion for nivolumab

Leopold-Franzens Universitaet Innsbruck patents KOR agonists

Zhejiang Hisun Pharmaceutical discloses romidepsin analogues

Cancer Research Technology describes HSF1 inhibitors

Merck KGaA develops ATM kinase inhibitors

Cynata reports promising preclinical findings for MSC technology in mouse model of asthma

Toray Industries presents analgesic agents

Novel BICD2 mutations may cause SMALED2

AbbVie receives positive opinion for Venclyxto tablets in patients with difficult-to-treat CLL

FDA grants orphan drug designation to Genentech's atezolizumab in SCLC

DNAJB6 mutation is associated with myofibrillar myopathies

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...